Pharmaceutical Technology1d
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
clinicaltrialsarena2d
Microbion reports topline data from Phase II study of DFI therapy
Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.
Hosted on MSN2d
California announces new law banning misunderstood grocery store labels — here's why other states should do the same
California is ready to say goodbye to a common labeling phrase at the grocery store that causes residents to waste major ...
clinicaltrialsarena3d
Longboard commences Phase III trial of bexicaserin for DEEs seizure treatment
Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...
The High Stakes Of Labeling—Costco’s Butter Recall, Explained
Costco recalls Kirkland butter over an unlabeled allergen. Learn why accurate food labeling is crucial for consumer trust and how to respond if you’re affected.